Medicaid generally pays for GLP-1 drugs such as Ozempic, Mounjaro and Trulicity for type 2 diabetes, but paying for Wegovy, Zepbound or Foundayo for weight loss is each state's choice. As of October 3, 2026, we confirmed 10 states that still do. Here is what most of them require, what people in other states can still do, how to check your own list and how to appeal a denial.